ACE and metabolic syndrome: It is doubtless that they are among the most potent DPP-IV and ACE inhibitor hydrolysates reported in the literature, suggesting that they may be successfully used as new valuable ingredients for the development of innovative functional foods and or dietary supplements for the prevention of cardiovascular disease and metabolic syndrome.